Engagement of monocytes, NK cells, and CD4(+) Th1 cells by ALVAC-SIV vaccination results in a decreased risk of SIV(mac251) vaginal acquisition

The recombinant Canarypox ALVAC-HIV/gp120/alum vaccine regimen was the first to significantly decrease the risk of HIV acquisition in humans, with equal effectiveness in both males and females. Similarly, an equivalent SIV-based ALVAC vaccine regimen decreased the risk of virus acquisition in Indian...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS Pathog
Hoofdauteurs: Gorini, Giacomo, Fourati, Slim, Vaccari, Monica, Rahman, Mohammad Arif, Gordon, Shari N., Brown, Dallas R., Law, Lynn, Chang, Jean, Green, Richard, Barrenäs, Fredrik, Liyanage, Namal P. M., Doster, Melvin N., Schifanella, Luca, Bissa, Massimiliano, Silva de Castro, Isabela, Washington-Parks, Robyn, Galli, Veronica, Fuller, Deborah H., Santra, Sampa, Agy, Michael, Pal, Ranajit, Palermo, Robert E., Tomaras, Georgia D., Shen, Xiaoying, LaBranche, Celia C., Montefiori, David C., Venzon, David J., Trinh, Hung V., Rao, Mangala, Gale, Michael, Sekaly, Rafick P., Franchini, Genoveffa
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2020
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7093029/
https://ncbi.nlm.nih.gov/pubmed/32163525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1008377
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items